Skip to contentI
Innoviva, Inc.
I
INVAInnoviva, Inc. Q4 2023 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$85.84M$85.84Mderived+30.4% vs Q4 2022 Net Income$61.53M$61.53MderivedN/M vs Q4 2022 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Innoviva, Inc. · CIK 1080014 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Cash Flowderived$33,256,000+273.7% Free Cash Flowderived$33,105,000+273.4% Margins · derivedNet margin71.7%+175.5 pt vs Q4 2022
ended Dec 31, 2023 · filed Feb 29, 2024 · 60 d after period end